142 related articles for article (PubMed ID: 24212987)
1. Low expression of MSH2 DNA repair protein is associated with poor prognosis in head and neck squamous cell carcinoma.
Pereira CS; Oliveira MV; Barros LO; Bandeira GA; Santos SH; Basile JR; Guimarães AL; De Paula AM
J Appl Oral Sci; 2013; 21(5):416-21. PubMed ID: 24212987
[TBL] [Abstract][Full Text] [Related]
2. Association between genetic polymorphisms in DNA mismatch repair-related genes with risk and prognosis of head and neck squamous cell carcinoma.
Nogueira GA; Lourenço GJ; Oliveira CB; Marson FA; Lopes-Aguiar L; Costa EF; Lima TR; Liutti VT; Leal F; Santos VC; Rinck-Junior JA; Lima CS
Int J Cancer; 2015 Aug; 137(4):810-8. PubMed ID: 25598504
[TBL] [Abstract][Full Text] [Related]
3. Deficiency of hMLH1 and hMSH2 expression is a poor prognostic factor in esophageal squamous cell carcinoma.
Uehara H; Miyamoto M; Kato K; Cho Y; Kurokawa T; Murakami S; Fukunaga A; Ebihara Y; Kaneko H; Hashimoto H; Murakami Y; Shichinohe T; Kawarada Y; Itoh T; Okushiba S; Kondo S; Katoh H
J Surg Oncol; 2005 Nov; 92(2):109-15. PubMed ID: 16231369
[TBL] [Abstract][Full Text] [Related]
4. p63 and Ki-67 immunostainings in laryngeal squamous cell carcinoma are related to survival.
Re M; Zizzi A; Ferrante L; Stramazzotti D; Goteri G; Gioacchini FM; Olivieri F; Magliulo G; Rubini C
Eur Arch Otorhinolaryngol; 2014 Jun; 271(6):1641-51. PubMed ID: 24402377
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of lncRNA WWTR1-AS1 associates with tumor aggressiveness and unfavorable survival in head-neck squamous cell carcinoma.
Li J; Li Z; Wu Y; Diao P; Zhang W; Wang Y; Yang J; Cheng J
J Cell Biochem; 2019 Oct; 120(10):18266-18277. PubMed ID: 31172583
[TBL] [Abstract][Full Text] [Related]
6. Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients.
Pavón MA; Arroyo-Solera I; Téllez-Gabriel M; León X; Virós D; López M; Gallardo A; Céspedes MV; Casanova I; López-Pousa A; Mangues MA; Quer M; Barnadas A; Mangues R
Oncotarget; 2015 Oct; 6(30):29016-33. PubMed ID: 26359694
[TBL] [Abstract][Full Text] [Related]
7. The expression of activin receptor-like kinase 1 among patients with head and neck cancer.
Chien CY; Chuang HC; Chen CH; Fang FM; Chen WC; Huang CC; Huang HY
Otolaryngol Head Neck Surg; 2013 Jun; 148(6):965-73. PubMed ID: 23447486
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of mutS homolog 2 and mutL homolog 1 affects overall survival in laryngeal squamous cell carcinoma patients: Investigation into a potential cause.
Gong HL; Shi Y; Shi Y; Wu CP; Cao PY; Zhou L; Xu C
Oncol Rep; 2013 Sep; 30(3):1371-9. PubMed ID: 23787767
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of iASPP in head and neck squamous cell carcinoma and its clinical significance.
Liu Z; Zhang X; Huang D; Liu Y; Zhang X; Liu L; Li G; Dai Y; Tan H; Xiao J; Tian Y
Med Oncol; 2012 Dec; 29(5):3381-8. PubMed ID: 22815155
[TBL] [Abstract][Full Text] [Related]
10. Specific TP53 mutations predict aggressive phenotype in head and neck squamous cell carcinoma: a retrospective archival study.
Peltonen JK; Vähäkangas KH; Helppi HM; Bloigu R; Pääkkö P; Turpeenniemi-Hujanen T
Head Neck Oncol; 2011 Apr; 3():20. PubMed ID: 21513535
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of WD repeat domain 5 associates with aggressive clinicopathological features and unfavorable prognosis in head neck squamous cell carcinoma.
Wu Y; Diao P; Li Z; Zhang W; Wang D; Wang Y; Cheng J
J Oral Pathol Med; 2018 May; 47(5):502-510. PubMed ID: 29569374
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma.
Li G; Ren S; Su Z; Liu C; Deng T; Huang D; Tian Y; Qiu Y; Liu Y
Tumour Biol; 2015 May; 36(5):3949-56. PubMed ID: 25578493
[TBL] [Abstract][Full Text] [Related]
13. Markers of epithelial to mesenchymal transition in association with survival in head and neck squamous cell carcinoma (HNSCC).
Pectasides E; Rampias T; Sasaki C; Perisanidis C; Kouloulias V; Burtness B; Zaramboukas T; Rimm D; Fountzilas G; Psyrri A
PLoS One; 2014; 9(4):e94273. PubMed ID: 24722213
[TBL] [Abstract][Full Text] [Related]
14. Association of Disease Recurrence With Survival Outcomes in Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Multimodality Therapy.
Sun L; Chin RI; Gastman B; Thorstad W; Yom SS; Reddy CA; Nussenbaum B; Wang SJ; Knackstedt T; Vidimos AT; Koyfman SA; Manyam BV
JAMA Dermatol; 2019 Apr; 155(4):442-447. PubMed ID: 30810715
[TBL] [Abstract][Full Text] [Related]
15. Expression of ERCC1, MSH2 and PARP1 in non-small cell lung cancer and prognostic value in patients treated with platinum-based chemotherapy.
Xie KJ; He HE; Sun AJ; Liu XB; Sun LP; Dong XJ
Asian Pac J Cancer Prev; 2014; 15(6):2591-6. PubMed ID: 24761869
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of cyclin D1 indicates a poor prognosis in squamous cell carcinoma of the head and neck.
Michalides RJ; van Veelen NM; Kristel PM; Hart AA; Loftus BM; Hilgers FJ; Balm AJ
Arch Otolaryngol Head Neck Surg; 1997 May; 123(5):497-502. PubMed ID: 9158396
[TBL] [Abstract][Full Text] [Related]
17. High expression of leucine zipper-EF-hand containing transmembrane protein 1 predicts poor prognosis in head and neck squamous cell carcinoma.
Chen L; Yang Y; Liu S; Piao L; Zhang Y; Lin Z; Li Z
Biomed Res Int; 2014; 2014():850316. PubMed ID: 24689060
[TBL] [Abstract][Full Text] [Related]
18. ELMO3 expression indicates a poor prognosis in head and neck squamous cell carcinoma - a short report.
Kadletz L; Heiduschka G; Wiebringhaus R; Gurnhofer E; Kotowski U; Haymerle G; Brunner M; Barry C; Kenner L
Cell Oncol (Dordr); 2017 Apr; 40(2):193-198. PubMed ID: 28039609
[TBL] [Abstract][Full Text] [Related]
19. Decreased mRNA expression levels of base excision repair (BER) pathway genes is associated with enhanced Ki-67 expression in HNSCC.
Mahjabeen I; Chen Z; Zhou X; Kayani MA
Med Oncol; 2012 Dec; 29(5):3620-5. PubMed ID: 22798271
[TBL] [Abstract][Full Text] [Related]
20. High RAB25 expression is associated with good clinical outcome in patients with locally advanced head and neck squamous cell carcinoma.
Téllez-Gabriel M; Arroyo-Solera I; León X; Gallardo A; López M; Céspedes MV; Casanova I; López-Pousa A; Quer M; Mangues MA; Barnadas A; Mangues R; Pavón MA
Cancer Med; 2013 Dec; 2(6):950-63. PubMed ID: 24403269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]